Last 12 months
Inside the activity.
8 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 1 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2022 Filed Jun 10, 2022 22:57 UTC |
UECKER DARRINDirector
|
PurchaseWarrant (right to buy) · Derivative | 7,365 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006921 · uecker-form4_060922.xml · derivative · entry 2 UECKER DARRIN · CIK 0001276311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,365 Underlying: Common Stock · 7,365 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 22:57 UTC |
UECKER DARRINDirector
|
OtherCommon Stock | 7,365 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006921 · uecker-form4_060922.xml · nonDerivative · entry 1 UECKER DARRIN · CIK 0001276311 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,376 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 22:59 UTC |
Zanganeh MahkamDirector
|
PurchaseWarrant (right to buy) · Derivative | 86,668 | Not disclosed Strike: $2.05 | Not disclosed |
DisclosureSEC source: 0001387131-22-006923 · zangeneh-form4_060922.xml · derivative · entry 5 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,668 Underlying: Common Stock · 86,668 shares Expires 2027-06-09 F2 · derivative.exercise_price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F1 · price: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 22:59 UTC |
Zanganeh MahkamDirector
|
OtherCommon Stock | 86,668 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001387131-22-006923 · zangeneh-form4_060922.xml · nonDerivative · entry 1 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,168 F1 · kind: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and the Prospectus Supplement and certain Current Reports on Form 8-K filed by the Issuer with the SEC. F2 · price: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $2.05 per unit, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at an exercise price of $2.05. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:51 UTC |
DUGGAN ROBERT WDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 110,467 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064001 · tm2216672-1_4seq1.xml · derivative · entry 2 DUGGAN ROBERT W · CIK 0001055919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,467 Underlying: Common Stock · 110,467 shares Expires 2032-05-19 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:51 UTC |
DUGGAN ROBERT WDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064001 · tm2216672-1_4seq1.xml · derivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:54 UTC |
Spray Shelley DDirector
|
GrantStock Option (right to buy) · Derivative | 35,047 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064006 · tm2216672-5_4seq1.xml · derivative · entry 2 Spray Shelley D · CIK 0001895909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,047 Underlying: Common Stock · 35,047 shares Expires 2032-05-19 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022. Read SEC document |
| May 19, 2022 Filed May 23, 2022 20:54 UTC |
Spray Shelley DDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064006 · tm2216672-5_4seq1.xml · derivative · entry 1 Spray Shelley D · CIK 0001895909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:54 UTC |
van den Broek RichardDirector
|
GrantStock Option (right to buy) · Derivative | 79,206 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064005 · tm2216672-4_4seq1.xml · derivative · entry 2 van den Broek Richard · CIK 0001431872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,206 Underlying: Common Stock · 79,206 shares Expires 2032-05-19 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:54 UTC |
van den Broek RichardDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064005 · tm2216672-4_4seq1.xml · derivative · entry 1 van den Broek Richard · CIK 0001431872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:52 UTC |
Zanganeh MahkamDirector
|
GrantStock Option (right to buy) · Derivative | 56,075 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064002 · tm2216672-2_4seq1.xml · derivative · entry 2 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,075 Underlying: Common Stock · 56,075 shares Expires 2032-05-19 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:52 UTC |
Zanganeh MahkamDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064002 · tm2216672-2_4seq1.xml · derivative · entry 1 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:53 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 116,005 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064004 · tm2216672-3_4seq1.xml · derivative · entry 2 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,005 Underlying: Common Stock · 116,005 shares Expires 2032-05-19 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on August 19, 2022. Read SEC document |
| May 19, 2022 Filed May 24, 2022 00:53 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001104659-22-064004 · tm2216672-3_4seq1.xml · derivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-05-19 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on June 19, 2022. Read SEC document |
| February 14, 2022 Filed Mar 22, 2022 20:11 UTC |
Danahy Kevin PatrickChief Commercial Office
|
GrantStock Option (right to buy) · Derivative | 300,000 | Not disclosed Strike: $6.41 | Not disclosed |
DisclosureSEC source: 0001104659-22-036559 · tm2210083-2_4seq1.xml · derivative · entry 1 Danahy Kevin Patrick · CIK 0001913245 · Chief Commercial Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2032-02-14 F2 · price: Not applicable. F1 · derivative.exercise_date: The option was granted on February 14, 2022 under the Issuer's 2017 Inducement Equity Incentive Plan. The shares subject to the option are subject to a mix of time-based and performance-based vesting criteria. 200,000 shares will vest in equal annual installments over the following four years on the anniversary of the grant date and 100,000 shares will vest in two equal annual installments on the third and fourth anniversaries of the grant date, in all cases, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| December 14, 2021 Filed Feb 28, 2022 18:42 UTC |
GARDINER SANDRA A.CFO & EVP Admin. and Finance
|
GrantStock Option (right to buy) · Derivative | 25,961 | $0.00 Strike: $13.94 | $0.00 |
DisclosureSEC source: 0000899243-22-008015 · doc4.xml · derivative · entry 1 GARDINER SANDRA A. · CIK 0001218574 · CFO & EVP Admin. and Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,922 Underlying: Common Stock · 25,961 shares Expires 2029-11-18 F1 · derivative.underlying_shares: On November 18, 2019, the reporting person was granted an option to purchase 103,842 shares of the issuer's common stock. The option vests based upon the achievement of performance objectives, with vesting targets no less than 25% vesting per year upon achievement of said objectives established by the Compensation Committee of the issuer, subject to the reporting person's continued service through each vesting date. The performance objectives for 2021 were met, resulting in the vesting of the option as to 25,961 shares. F2 · balance_after: Represents the options which vested on the 2020 vesting date and the options which vested on the 2021 vesting date. Read SEC document |
| November 24, 2021 Filed Nov 29, 2021 16:06 UTC |
Spray Shelley DDirector
|
GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $21.70 | $0.00 |
DisclosureSEC source: 0001104659-21-144422 · tm2134098-2_4seq1.xml · derivative · entry 1 Spray Shelley D · CIK 0001895909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2031-11-24 F1 · derivative.exercise_date: One-third (1/3) of the shares subject to the option will vest on November 24, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two-year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| October 04, 2021 Filed Oct 6, 2021 16:11 UTC |
DEBUONO LAUREENDirector
|
GrantStock Option (right to buy) · Derivative | 32,500 | $0.00 Strike: $20.33 | $0.00 |
DisclosureSEC source: 0001209191-21-059813 · doc4.xml · derivative · entry 1 DEBUONO LAUREEN · CIK 0001034447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2031-10-04 F1 · derivative.exercise_date: One-third (1/3) of the shares subject to the option will vest on October 4, 2022, and the remaining shares will vest in equal monthly installments thereafter over the following two year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 16:22 UTC |
Levinson Mitchell E.Director · Chief Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 65,510 | $0.00 Strike: $21.12 | $0.00 |
DisclosureSEC source: 0001209191-21-052766 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,510 Underlying: Common Stock · 65,510 shares Expires 2031-08-19 F1 · derivative.exercise_date: 50% of the shares subject to the option will vest in equal annual installments on the second, third and fourth anniversary of the grant date, and the other 50% of the shares subject to the option will vest upon the achievement of performance objectives established by the Compensation Committee of the Issuer, with vesting targets set at 25% (8,188 option shares) over the following four years on the anniversary of the grant date. All vesting is subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 20:48 UTC |
DUGGAN ROBERT WDirector · 10% owner
|
PurchaseCommon Stock | 3,048,780 | $16.40 | $49,999,992.00 |
DisclosureSEC source: 0001209191-21-045022 · doc4.xml · nonDerivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,708,561 F1 · kind: Shares were acquired pursuant to the terms of that certain purchase agreement by and between the Reporting Person and the Issuer, of which consideration included the satisfaction of a loan from the Reporting Person to the Issuer. Read SEC document |
| June 01, 2021 Filed Jun 3, 2021 21:37 UTC |
Ebbers EdEVP & GM, Dermatology
|
Tax withholdingCommon Stock | 1,485 | $18.76 | $27,858.60 |
DisclosureSEC source: 0001209191-21-037810 · doc4.xml · nonDerivative · entry 1 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,300 F1 · kind: Represents the total number of shares withheld by the Company to settle the Reporting Person's minimum tax liability pursuant to the contractual provisions of the June 2018 Restricted Stock Unit grant agreement previously disclosed. F2 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:04 UTC |
DUGGAN ROBERT WDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,605 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035005 · doc4.xml · derivative · entry 2 DUGGAN ROBERT W · CIK 0001055919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,605 Underlying: Common Stock · 11,605 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:04 UTC |
DUGGAN ROBERT WDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035005 · doc4.xml · derivative · entry 1 DUGGAN ROBERT W · CIK 0001055919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:06 UTC |
Levinson Mitchell E.Director
|
GrantStock Option (right to buy) · Derivative | 45,987 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035007 · doc4.xml · derivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,987 Underlying: Common Stock · 45,987 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:06 UTC |
Levinson Mitchell E.Director
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035007 · doc4.xml · derivative · entry 1 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:08 UTC |
van den Broek RichardDirector
|
GrantStock Option (right to buy) · Derivative | 9,069 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035012 · doc4.xml · derivative · entry 2 van den Broek Richard · CIK 0001431872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,069 Underlying: Common Stock · 9,069 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:08 UTC |
van den Broek RichardDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035012 · doc4.xml · derivative · entry 1 van den Broek Richard · CIK 0001431872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:09 UTC |
Zanganeh MahkamDirector
|
GrantStock Option (right to buy) · Derivative | 8,026 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035015 · doc4.xml · derivative · entry 2 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,026 Underlying: Common Stock · 8,026 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:09 UTC |
Zanganeh MahkamDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035015 · doc4.xml · derivative · entry 1 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:05 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 8,026 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035006 · doc4.xml · derivative · entry 2 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,026 Underlying: Common Stock · 8,026 shares Expires 2031-05-20 F2 · derivative.exercise_date: The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 17:05 UTC |
Clark Kenneth ADirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035006 · doc4.xml · derivative · entry 1 Clark Kenneth A · CIK 0001561736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:07 UTC |
Soni Manmeet SinghDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.69 | $0.00 |
DisclosureSEC source: 0001209191-21-035010 · doc4.xml · derivative · entry 1 Soni Manmeet Singh · CIK 0001569769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 22:18 UTC |
GARDINER SANDRA A.CFO & EVP Admin. and Finance
|
GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001209191-21-022928 · doc4.xml · derivative · entry 3 GARDINER SANDRA A. · CIK 0001218574 · CFO & EVP Admin. and Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2031-03-22 F3 · derivative.exercise_date: The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 22:15 UTC |
UECKER DARRINDirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 54,750 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001209191-21-022926 · doc4.xml · derivative · entry 2 UECKER DARRIN · CIK 0001276311 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,750 Underlying: Common Stock · 54,750 shares Expires 2031-03-22 F2 · derivative.exercise_date: The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 22:17 UTC |
Ebbers EdEVP & GM, Dermatology
|
GrantStock Option (right to buy) · Derivative | 15,875 | $0.00 Strike: $24.03 | $0.00 |
DisclosureSEC source: 0001209191-21-022927 · doc4.xml · derivative · entry 2 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,875 Underlying: Common Stock · 15,875 shares Expires 2031-03-22 F2 · derivative.exercise_date: The shares subject to the option will vest in equal annual installments over the following four years on the anniversary of March 1, 2021, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| February 23, 2021 Filed Mar 24, 2021 22:18 UTC |
GARDINER SANDRA A.CFO & EVP Admin. and Finance
|
GrantStock Option (right to buy) · Derivative | 8,750 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-21-022928 · doc4.xml · derivative · entry 2 GARDINER SANDRA A. · CIK 0001218574 · CFO & EVP Admin. and Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,750 Underlying: Common Stock · 8,750 shares Expires 2030-05-18 F2 · shares: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. F2 · derivative.exercise_date: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. Read SEC document |
| February 23, 2021 Filed Mar 24, 2021 22:15 UTC |
UECKER DARRINDirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-21-022926 · doc4.xml · derivative · entry 1 UECKER DARRIN · CIK 0001276311 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-18 F1 · shares: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. F1 · derivative.exercise_date: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. Read SEC document |
| February 23, 2021 Filed Mar 24, 2021 22:17 UTC |
Ebbers EdEVP & GM, Dermatology
|
GrantStock Option (right to buy) · Derivative | 37,500 | $0.00 Strike: $10.66 | $0.00 |
DisclosureSEC source: 0001209191-21-022927 · doc4.xml · derivative · entry 1 Ebbers Ed · CIK 0001643353 · EVP & GM, Dermatology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-18 F1 · shares: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. F1 · derivative.exercise_date: Represents the acquisition of vested options upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met in 2020 with respect to performance-based stock options granted to the Reporting Person on May 18, 2020. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:12 UTC |
UECKER DARRINDirector · CEO and President
|
OtherWarrant (right to buy) · Derivative | 1,284 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005359 · doc4.xml · derivative · entry 2 UECKER DARRIN · CIK 0001276311 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,284 shares Expires 2025-06-15 Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 21:12 UTC |
UECKER DARRINDirector · CEO and President
|
OtherCommon Stock | 1,284 | $7.01 | $9,000.84 |
DisclosureSEC source: 0001209191-21-005359 · doc4.xml · nonDerivative · entry 1 UECKER DARRIN · CIK 0001276311 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,893 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 9 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 8 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherWarrant (right to buy) · Derivative | 19 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 7 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 0 Underlying: Common Stock · 19 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherWarrant (right to buy) · Derivative | 107 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · derivative · entry 6 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 0 Underlying: Common Stock · 107 shares Expires 2025-06-15 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 5 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 4 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherCommon Stock | 19 | $7.01 | $133.19 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 3 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate family member Disclosed balance after: 591 Read SEC document |
| January 20, 2021 Filed Jan 27, 2021 21:02 UTC |
Levinson Mitchell E.Director
|
OtherCommon Stock | 107 | $7.01 | $750.07 |
DisclosureSEC source: 0001209191-21-005805 · doc4.xml · nonDerivative · entry 2 Levinson Mitchell E. · CIK 0001674465 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Disclosed balance after: 3,321 Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:32 UTC |
Zanganeh MahkamDirector
|
OtherWarrant (right to buy) · Derivative | 307 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0001209191-21-004669 · doc4.xml · derivative · entry 6 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 0 Underlying: Common Stock · 307 shares Expires 2025-06-15 Read SEC document |
| January 19, 2021 Filed Jan 21, 2021 21:32 UTC |
Zanganeh MahkamDirector
|
OtherCommon Stock | 307 | $7.01 | $2,152.07 |
DisclosureSEC source: 0001209191-21-004669 · doc4.xml · nonDerivative · entry 2 Zanganeh Maky · CIK 0001507650 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Immediate Family Member 1 Disclosed balance after: 107,074 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.